[Retracted] Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?

Table 1

Baseline patient characteristics (% in brackets).

Characteristic	Intracoronary adenosine (𝑛=40)	Intravenous adenosine (𝑛=40)
Age (years)	61.0	59.8
Male gender	30 (75)	32 (80)
Heart rate (b.p.m.)	96	87
Systolic blood pressure (mm Hg)	156	162
Diastolic blood pressure (mm Hg)	98	104
Current smoker	26 (65)	30 (75)
History
Myocardial infarction	6 (15)	4 (10)
Diabetes mellitus	6 (15)	2 (5)
PCI	4 (10)	2 (5)
Family history	12 (30)	10 (25)
Hypertension	18 (45)	22 (55)
Hypercholesterolaemia	12 (30)	22 (55)
Door-to-balloon time (median, IQR), min	16.1	15.8
Angiographic
Infarct-related vessel
RCA	20 (50)	22 (55)
LAD	18 (45)	16 (40)
Cx	2 (5)	2 (5)
TIMI flow before PCI
0	32 (80)	20 (50)
1	4 (10)	12 (30)
2	4 (10)	8 (20)
3	0 (0)	0 (0)
0/1	36 (90)	32 (80)
2/3	4 (10)	8 (20)
Stent diameter, mm	3.0	3.0
Stent length, mm	19.5	21.7
GPIIb/IIIa inhibitor during PCI	40 (100)	40 (100)